China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies

China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies

Cancer is one of the biggest burdens for so many public health departments across the world and China has even more cancer patients due to growing population at rapid pace. According to GLOBCAN, nearly 2.9 Million new cancer deaths happened in China in the year 2018. If we talk about cancer incidence, this rate is much lower in China rather than United States and United Kingdom. But when we talk about mortality rate, China mortality rate is almost 30% to 40% higher than the United States and United Kingdom. Moreover, increasing diagnostic center, improving cancer treatment therapy and acceptance of targeted drug therapy will further boost the China cancer market in forecast period. However, expensive cancer drug and various side-effects will also hinder the market. According to Renub Research Analysis, China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025.

China cancer drug market has grown rapidly in historical period and it is expected to grow significantly during the forecast period. There are various factors that will help the market to outperform; rising ageing population in China, changes of lifestyle and food habits, rising incidence rate of several type of cancer, rise in tobacco smoking population due to expansion of urbanization in China, improving healthcare infrastructure and facilities in China, increasing per capita disposable income, rising per capita healthcare expenditure, improving awareness regarding cancer risk, potential due to emerging economies etc.

Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

China Cancer Drug Market Insight by Drug Type

In this report, China cancer drugs market is fragmented by drug type into six parts; Targeted Drugs, Cytotoxic Drugs, Monoclonal Antibiotics, Hormonal Drugs, TCM and Others. Cytotoxic Drugs type is further categorized into three parts; Antimetabolites, Plant Alkaloids and Alkylating Agents. Currently targeted drugs have more ability to kill malignant cells and it is quite popular because of higher success rate and efficacy.

China Cancer Drug Market Insight by Types of Cancer

In this report, we have done in-depth analysis of market by types of cancer; Lung, Stomach, Breast, Esophageal, Liver & Others.

China Cancer Drug Market Insight by Therapy

According Renub Research, targeted drug therapy is growing significantly in China due its higher efficacy and success rate than other therapy. In this report, we have design multi-dimensional approach to study all the cancer therapy which includes various important variables such as prime factors that support market growth, opportunities in each therapy, challenges faced by particular therapy etc.

By Drugs
Cytotoxic Drugs
o Antimetabolities
o Plant Alkaloids
o Alkylating Agents
Targeted Drugs
Monoclonal Antibiotics
Hormonal Drugs
Traditional Chinese Medicine (TCM)
Others

By Cancer

Lung Cancer
Stomach Cancer
Breast Cancer
Esophageal Cancer
Liver Cancer
Others

By Therapy

Chemotherapy
Targeted Therapy
Hormonal Therapy
Others

Companies Covered in the Report

Merck
Celegene
Eli Lilly
Roche
Sino BioPharma


1. Executive Summary
2. China Cancer Drugs Market
3. Market Share – China Anti-Cancer Drugs
3.1 By Drugs
3.2 By Cancer
3.3 By Therapy
4. Drugs – China Cancer Market
4.1 Cytotoxic Drugs
4.1.1 Antimetabolities
4.1.2 Plant Alkaloids
4.1.3 Alkylating Agents
4.2 Targeted Drugs
4.3 Monoclonal Antibiotics
4.4 Hormonal Drugs
4.5 Traditional Chinese Medicine (TCM)
4.6 Others
5. Cancer Type – Market
5.1 Lung Cancer
5.2 Stomach Cancer
5.3 Breast Cancer
5.4 Esophageal Cancer
5.5 Liver Cancer
5.6 Others
6. Therapy – China Cancer Market
6.1 Chemotherapy
6.2 Targeted Therapy
6.3 Hormonal Therapy
6.4 Others
7. Company Analysis
7.1 Merck
7.1.1 Company Overview
7.1.2 Financial Insights
7.2 Celgene
7.2.1 Company Overview
7.2.2 Financial Insights
7.3 Eli Lilly
7.3.1 Company Overview
7.3.2 Financial Insights
7.4 Roche
7.4.1 Company Overview
7.4.2 Financial Insights
7.5 Sino BioPharma
7.5.1 Company Overview
7.5.2 Financial Insights
8. Growth Drivers
8.1 Growing Awareness towards Cancer Diagnosis and Treatment
8.2 Increasing Use of Targeted Therapy
8.3 Increasing Research and Development Activities
8.4 Cutting Import Duties on Cancer Drugs
9. Challenges
9.1 High Cost of Cancer Drugs
9.2 Major Side Effects of Cancer Treatment
List of Figures:
Figure 2 1: China – Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 2 2: China – Forecast for Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 3 1: By Drugs – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3 2: By Drugs – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 3 3: By Cancer – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3 4: By Cancer – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 3 5: By Therapy – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3 6: By Therapy – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 4 1: Cytotoxic Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 2: Cytotoxic Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 3: Antimetaboloties – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 4: Antimetaboloties – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 5: Plant Alkaloids – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 6: Plant Alkaloids – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 7: Alkylating Agents – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 8: Alkylating Agents – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 9: Targeted Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 10: Targeted Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 11: Monoclonal Antibiotics – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 12: Monoclonal Antibiotics – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 13: Hormonal Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 14: Hormonal Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 15: Traditional Chinese Medicine (TCM) – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4 16: Traditional Chinese Medicine (TCM) – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4 17: Others – China Anti-Cancer Drugs Market (Million US$), 2011 – 2017
Figure 4 18: Others – Forecast for China Anti-Cancer Drugs Market (Million US$), 2018 – 2024
Figure 5 1: Lung Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5 2: Lung Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5 3: Stomach Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5 4: Stomach Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5 5: Breast Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5 6: Breast Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5 7: Esophageal Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5 8: Esophageal Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5 9: Liver Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5 10: Liver Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 5 11: Others – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 5 12: Others – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6 1: Chemotherapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6 2: Chemotherapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6 3: Targeted Therapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6 4: Targeted Therapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6 5: Hormonal Therapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6 6: Hormonal Therapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 6 7: Others – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 6 8: Others – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 7 1: Merck – Global Oncology Product Sales (Million US$), 2011 – 2017
Figure 7 2: Merck – Forecast for Global Oncology Product Sales (Million US$), 2018 – 2024
Figure 7 3: Celgene – Global Net Product Sales (Million US$), 2011 – 2017
Figure 7 4: Celgene – Forecast for Global Net Product Sales (Million US$), 2018 – 2024
Figure 7 5: Eli Lilly – Global Oncology Revenue (Million US$), 2011 – 2017
Figure 7 6: Eli Lilly – Forecast for Global Oncology Revenue (Million US$), 2018 – 2024
Figure 7 7: Roche – Global Oncology Products Sales (Million US$), 2011 – 2017
Figure 7 8: Roche – Forecast for Global Oncology Products Sales (Million US$), 2018 – 2024
Figure 7 9: Sino BioPharma – Global Oncology Revenue (Million US$), 2012 – 2017
Figure 7 10: Sino BioPharma – Forecast for Global Oncology Revenue (Million US$), 2018 – 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook